The FDA rejected Norvartis’ bid to expand the indications for canakinumab to include cardiovascular risk reduction among heart attack survivors, Reuters reported Oct. 18.
Patients with heart disease should aim to be physically active seven minutes for every 20 they’re sedentary to prolong life and prevent further cardiovascular damage, according to research presented at the 2018 Canadian Cardiovascular Congress in Toronto.
DUBLIN — October 21, 2018 — Medtronic plc (NYSE:MDT) announced today that its co-founder, Earl E. Bakken, passed away peacefully on October 21, 2018 at his home on Kiholo Bay on the Big Island of Hawaii. He was 94 years old.
Aspirin alone may be sufficient to balance the risks of venous thromboembolism (VTE) and bleeding following total knee replacement surgery, according to a study published online in JAMA Surgery.
Recreational marijuana use is linked to an increase in stroke prevalence in the U.S. population, according to a study presented at the 11th World Stroke Congress in Montreal. Results of the study were released just two days after Canada legalized recreational cannabis nationwide.
Officials in Clark County, Indiana, are urging locals to download a new phone app that would alert CPR-certified individuals to cardiac arrests happening nearby. An accompanying app also maps out the county’s nearest automated external defibrillators.
A novel risk score incorporating patient demographics and clinical characteristics known ahead of hospital discharge can accurately identify CVD patients at low and high risk for 90-day readmission after an initial acute MI (AMI), according to research published in the October edition of Circulation: Cardiovascular Quality and Outcomes.
Cardiologists and researchers alike are calling for the early halt of a national heart stem cell trial after Harvard Medical School and Brigham and Women’s Hospital expressed concern earlier this week that some of the work the study is based on might be falsified.
The HeartMate 3 left ventricular assist device (LVAD) has gained FDA approval for advanced heart failure patients ineligible for a transplant, manufacturer Abbott announced Oct. 19.
Transcranial duplex sonography (TCD) can assess middle cerebral artery blood flow and provide prognostic information for stroke patients after thrombectomy for large vessel occlusions, suggests a report published Oct. 15 in Stroke.
